Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...

Evidence for this comes from trials where lifestyle change and/or glucose-lowering medications decreased progression from prediabetes to diabetes. After withdrawal of these interventions ...

Addressing reporters, Trump said that Bolton, his former US National Security Adviser, no longer has the protection, because "you can't have that for life." In response, Bolton, who faces the alleged ...

Liam Gallagher appears to be putting his partying days (mostly) behind him as he makes a big change ahead of the Oasis reunion tour. Oasis Live ’25 is one of the most highly-anticipated tours ...

Eli Lilly and Boehringer Ingelheim's blockbuster diabetes drug Jardiance (empagliflozin ... In a new white paper from Altmetric – ‘The changing landscape of journal performance measurement ...

Sligo University Hospital has apologised to an 82-year-old woman whose throat was perforated during a routine endoscopic procedure, leaving her with life-changing injuries. The apology was read at ...

Prince Harry will not be returning to the UK this week for his trial. The Duke of Sussex, who was expected to travel to his home country for the trial against Rupert Murdoch’s News Group ...

"I'm married and I have two daughters, 7 and 3, and they're the most important things in my life," he said, "And I want to make sure that I'm around them for as long as possible." ANDERSON ...

To be in the flesh with Richard Linklater and Ethan Hawke and be able to not only witness their process but be a part of it was life-changing.” Qualley’s collaborations with auteurs like ...

The drug is chasing a market where Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin) SGLT2 inhibitor looks likely to be the new pacesetter. It became the first ever diabetes drug to ...